ADICET BIO INC (ACET)

US0070021086 - Common Stock

0.9091  +0.04 (+4.49%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
17.9M9.73M
-45.64%
24.99M
156.83%
637.5K
-100.00%
4.08M4.08M35.164M
761.86%
87.381M
148.50%
66.861M
-23.48%
169.81M
153.97%
85.476M
-49.66%
135.32M
58.31%
EBITDA
YoY % growth
-37.96M
55.51%
-58.69M
-54.61%
-69.97M
-19.22%
-159.12M
-80.76%
-156.06M
-23.39%
-176.46M
-13.07%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-39.19M
54.14%
-60.23M
-53.69%
-72.55M
-20.45%
-153.056M
-82.74%
-133.443M
-0.65%
-141.933M
-6.36%
-152.403M
-7.38%
-111.296M
26.97%
-73.739M
33.75%
-132.985M
-80.35%
-88.643M
33.34%
-138.383M
-56.11%
-111.459M
19.46%
Operating Margin
-218.94%-619.01%-290.32%-24,008.71%N/A-3,478.75%-3,735.38%-316.51%-84.39%-198.90%-52.20%-161.90%-82.37%
EPS
YoY % growth
-5.68
65.62%
-2.07
63.56%
-1.71
17.39%
-3.39
-94.15%
-1.41
57.58%
-1.39
1.61%
-1.04
24.91%
-0.73
29.66%
-0.19
73.98%
-0.98
-416.87%
-0.23
76.17%
-1.04
-343.48%
-0.68
34.31%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.37
46.46%
-0.35
-0.83%
-0.37
-11.48%
-0.38
-11.40%
-0.35
5.75%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-34.656M
-9.79%
-35.873M
-16.20%
-37.279M
-13.49%
-38.396M
-15.81%
-39.835M
-14.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.34
70.69%
-0.350.012.10%
Q2 2024
Q2Q % growth
-0.33
56.00%
-0.370.0411.06%
Q1 2024
Q2Q % growth
-0.35
51.39%
-0.400.0511.52%
Q4 2023
Q2Q % growth
-0.69
4.17%
-0.710.022.60%
Q3 2023
Q2Q % growth
-1.16
-118.87%
-0.75-0.41-54.25%
Q2 2023
Q2Q % growth
-0.75
-33.93%
-0.70-0.05-7.88%
Q1 2023
Q2Q % growth
-0.72
-820.00%
-0.70-0.02-2.71%
Q4 2022
Q2Q % growth
-0.72
-53.19%
-0.28-0.44-153.00%
Q3 2022
Q2Q % growth
-0.53
-20.45%
-0.540.011.40%
Q2 2022
Q2Q % growth
-0.56
-64.71%
-0.46-0.10-20.66%
Q1 2022
Q2Q % growth
0.10
112.20%
-0.190.29153.87%
Q4 2021
Q2Q % growth
-0.47
-2.17%
-0.43-0.04-9.39%
Q3 2021
Q2Q % growth
-0.44
84.51%
-0.450.011.96%
Q2 2021
Q2Q % growth
-0.34
67.62%
-0.540.2037.11%
Q1 2021
Q2Q % growth
-0.82
38.35%
-0.50-0.32-64.63%
Q4 2020
Q2Q % growth
-0.46
91.68%
-0.900.4448.75%
Q3 2020
Q2Q % growth
-2.84
40.34%
-0.83-2.01-241.63%
Q2 2020
Q2Q % growth
-1.05
70.59%
-1.780.7340.94%
Q1 2020
Q2Q % growth
-1.33
50.00%
-2.401.0744.64%
Q4 2019
Q2Q % growth
-5.53 -4.48-1.05-23.46%
Q3 2019
Q2Q % growth
-4.76 -3.84-0.92-23.97%
Q2 2019
Q2Q % growth
-3.57 -2.80-0.77-27.55%
Q1 2019
Q2Q % growth
-2.66 -2.57-0.09-3.49%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
637.5K-637.5K-100.00%
Q4 2023
Q2Q % growth
637.5K-637.5K-100.00%
Q3 2023
Q2Q % growth
1.133M-1.133M-100.00%
Q2 2023
Q2Q % growth
12.92M-12.92M-100.00%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth

-100.00%
11.787M-11.787M-100.00%
Q3 2022
Q2Q % growth

-100.00%
339.997K-339.997K-100.00%
Q2 2022
Q2Q % growth

-100.00%
994.5K-994.5K-100.00%
Q1 2022
Q2Q % growth
24.99M
727.89%
13.964M11.026M78.96%
Q4 2021
Q2Q % growth
5.47M
1.11%
4.246M1.224M28.83%
Q3 2021
Q2Q % growth
3.43M
13.20%
2.739M691K25.23%
Q2 2021
Q2Q % growth
4.81M
-49.21%
1.87M2.94M157.22%
Q1 2021
Q2Q % growth
-3.98M 680.003K-4.66M-685.29%
Q3 2020
Q2Q % growth
3.03M
142.98%
3.03M%
Q2 2020
Q2Q % growth
9.47M
56.01%
9.47M%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 1.9% 0% -0.81%
RevenueN/A N/A N/A N/A